For the manufacture, distribution or import of radiopharmaceuticals with a view to their distribution, generators or precursors as defined in Article L. 5121-1, the application for authorisation shall be accompanied by a document establishing that an application for authorisation to open a pharmaceutical establishment has been submitted in accordance with Article L. 5124-3 or that the applicant has an authorisation for a pharmaceutical establishment in force. Any issue, modification, suspension,…